CRISTIN CAMPBELL: Open Payments
NPI 1235731670 · DAVENPORT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,180 in 46 payments from 11 companies in 2025. Trend: 2023 $365 · 2024 $1,176 · 2025 $1,180
Food & beverage: $1,090Education: $89
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $499 |
| Janssen Biotech, Inc. | 6 | $181 |
| Phathom Pharmaceuticals, Inc. | 7 | $164 |
| Gilead Sciences, Inc. | 4 | $106 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| PFIZER INC. | 3 | $58 |
| Novo Nordisk Inc | 1 | $30 |
| Madrigal Pharmaceuticals | 1 | $28 |
| Intercept Pharmaceuticals, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
Products named: RINVOQ, TREMFYA, VOQUEZNA, SKYRIZI, DUPIXENT, LINZESS, XELJANZ, Wegovy.
Industry payments across FL — which companies pay providers there.
